Skip to Content

LBA: Oral Vitamin C Supplementation for Patients with Early-Stage Myeloid Malignancies and Precursor Conditions Might Improve OS

Watch Stine Ulrik Mikkelsen from Rigshospitalet, Denmark, discuss her late-breaking abstract, which was just presented at the Late-Breaking Oral Session at EHA 2024. The study shows that there is significant potential for vitamin C supplementation to improve OS in patients with low-risk myeloid malignancies and precursor diseases.

Stine Ulrik Mikkelsen

Få tillgång

Om du är läkare, sjuksköterska eller annan vårdpersonal kan du komma åt hela artikeln genom att skapa en profil på BestPractice Nordic.

Back to top